微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 3.3% | 139.13% | 70.98% | 23/52 | 3.3% | 澳洋健康 | 25.95% | 行业排名> |
| 2025-06-30 | 1.93% | 129.76% | 67.83% | 23/52 | 1.68% | 澳洋健康 | 19.74% | 行业排名> |
| 2025-03-31 | 1.15% | 248.48% | 150% | 24/52 | 0.99% | 澳洋健康 | 12.87% | 行业排名> |
| 2024-12-31 | 0.46% | -82.24% | -66.67% | 29/52 | -1.11% | 澳洋健康 | 28.53% | 行业排名> |
| 2024-09-30 | 1.38% | -65.76% | 64.29% | 31/52 | 3.33% | 澳洋健康 | 34.16% | 行业排名> |
| 2024-06-30 | 0.84% | -71.33% | 154.55% | 31/52 | 1.9% | 澳洋健康 | 30.56% | 行业排名> |
| 2024-03-31 | 0.33% | -75.74% | -87.26% | 31/52 | 1.19% | 澳洋健康 | 28.14% | 行业排名> |
| 2023-12-31 | 2.59% | -79.25% | -35.73% | 31/52 | 2.79% | 澳洋健康 | 39.54% | 行业排名> |
| 2023-09-30 | 4.03% | -58.92% | 37.54% | 29/52 | 6.82% | 澳洋健康 | 61.84% | 行业排名> |
| 2023-06-30 | 2.93% | -45.03% | 115.44% | 27/52 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
| 2023-03-31 | 1.36% | 2% | -89.1% | 29/52 | 2.58% | 澳洋健康 | 58.19% | 行业排名> |
| 2022-12-31 | 12.48% | -45.64% | 27.22% | 18/52 | -1.81% | *ST宜康 | 75.53% | 行业排名> |
| 2022-09-30 | 9.81% | -36.71% | 84.05% | 19/52 | 11.4% | 博腾股份 | 39.77% | 行业排名> |
| 2022-06-30 | 5.33% | -32.36% | -76.79% | 20/52 | 5.56% | 睿智医药 | 41.16% | 行业排名> |
| 2021-12-31 | 22.96% | 29.06% | 191.37% | 9/52 | -7.44% | 澳洋健康 | 51.68% | 行业排名> |
| 2021-06-30 | 7.88% | -36.66% | -55.71% | 16/52 | 2.28% | 澳洋健康 | 40.93% | 行业排名> |
| 2020-12-31 | 17.79% | -27.03% | 14.77% | 18/52 | 10.95% | 金域医学 | 43.58% | 行业排名> |
| 2020-09-30 | 15.5% | 2% | -36.42% | 10/52 | 7.83% | 金域医学 | 35.41% | 行业排名> |
| 2019-12-31 | 24.38% | 538.22% | 95.98% | 8/52 | 65.31% | 阳光诺和 | 26.2% | 行业排名> |
| 2019-06-30 | 12.44% | 718.42% | 225.65% | 3/52 | 5.65% | 金域医学 | 13.23% | 行业排名> |
| 2018-12-31 | 3.82% | 2% | 151.32% | 32/52 | -0.6% | 万邦医药 | 52.05% | 行业排名> |
| 2018-06-30 | 1.52% | 2% | 2% | 25/52 | 1.51% | 华大基因 | 48.52% | 行业排名> |